
Clinical Trials
LUCIDITY, a new clinical trial examining the effects of LMTX® in patients with mild Alzheimer’s disease, is now underway. Find out more
LUCIDITY, a new clinical trial examining the effects of LMTX® in patients with mild Alzheimer’s disease, is now underway. Find out more
The tau tangle pathway is a key driver of Alzheimer’s disease leading to loss of neuronal function, spread of pathology and clinical symptoms. Find out more
TauRx’s tau aggregation inhibitors are the outcome of nearly 30 years of research, preclinical and clinical investigations. Find out more
Through TauRx’s technology platform, the company is continuing to discover and develop new treatments and diagnostic compounds. Find out more